Intravitreal injection of NGF has been used in the Royal College of Surgeons (RCS) rat model of retinitis pigmentosa, and the investigators believed the protective effect was associated with an increase in Trk-A and activated pTrk-A levels [35]. This evidence concerns the gene NTRK1 and retinitis pigmentosa.